Mast cell tryptase-role in the investigation of acute hypersensitivity reactions

Current Anaesthesia and Critical Care

Volumn 17, Issue 1-2, 2006, Pages 29-35

  Payne, V ^a   Kam, P C A ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Adverse events; Anaesthesia; Anaphylaxis; Mast cell; Tryptase

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; HISTAMINE; IMMUNOGLOBULIN E; LATEX; MUSCLE RELAXANT AGENT; PENICILLIN G; PROTEINASE ACTIVATED RECEPTOR 2; ROCURONIUM; SERINE PROTEINASE; SUXAMETHONIUM; TRYPTASE;

AIRWAY DYNAMICS; ALLERGY; ANGIOGENESIS; ARTICLE; CELL GRANULE; CELLULAR DISTRIBUTION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; ENZYME ANALYSIS; ENZYME RELEASE; GRANULOCYTE; HISTAMINE RELEASE; HOMEOSTASIS; HUMAN; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; INTESTINE ABSORPTION; INTESTINE MUSCLE; MAST CELL; MAST CELL DEGRANULATION; MEDICAL ASSESSMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SMOOTH MUSCLE CONTRACTION; STOMACH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 33748422478     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2006.03.006     Document Type: Article

References (55)

1. Krishnaswamy G., Kelley J., Johnson D., Youngberg G., Stone W., Huang S.K., et al. The human mast cell: functions in physiology and disease. Front Biosci 6 (2001) D1109-D1127
2. Schwartz L.B. Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. Leuk Res 25 7 (2001) 553-562
3. Ren S., Sakai K., and Schwartz L.B. Regulation of human mast cell beta-tryptase: conversion of inactive monomer to active tetramer at acid pH. J Immunol 160 9 (1998) 4561-4569
4. Fajardo I., and Pejler G. Formation of active monomers from tetrameric human beta-tryptase. Biochem J 369 Part 3 (2003) 603-610
5. Alter S.C., Kramps J.A., Janoff A., and Schwartz L.B. Interactions of human mast cell tryptase with biological protease inhibitors. Arch Biochem Biophys 276 1 (1990) 26-31
6. Sakai K., Ren S., and Schwartz L.B. A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I. J Clin Invest 97 4 (1996) 988-995
7. Cairns J.A., and Walls A.F. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol 156 1 (1996) 275-283
8. Brown J.K., Tyler C.L., Jones C.A., Ruoss S.J., Hartmann T., and Caughey G.H. Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells. Am J Respir Cell Mol Biol 13 2 (1995) 227-236
9. Ruoss S.J., Hartmann T., and Caughey G.H. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 88 2 (1991) 493-499
10. Cairns J.A., and Walls A.F. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 99 6 (1997) 1313-1321
11. Gruber B.L., Kew R.R., Jelaska A., Marchese M.J., Garlick J., Ren S., et al. Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 158 5 (1997) 2310-2317
12. Compton S.J., Cairns J.A., Holgate S.T., and Walls A.F. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J Immunol 161 4 (1998) 1939-1946
13. He S., Gaca M.D., and Walls A.F. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase. J Pharmacol Exp Ther 286 1 (1998) 289-297
14. Lan R.S., Stewart G.A., and Henry P.J. Role of protease-activated receptors in airway function: a target for therapeutic intervention?. Pharmacol Ther 95 3 (2002) 239-257
15. Kawabata A., and Kuroda R. Protease-activated receptor (PAR), a novel family of G protein-coupled seven trans-membrane domain receptors: activation mechanisms and physiological roles. Jpn J Pharmacol 82 3 (2000) 171-174
16. Nystedt S., Emilsson K., Wahlestedt C., and Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91 20 (1994) 9208-9212
17. Lan R.S., Stewart G.A., and Henry P.J. Role of protease-activated receptors in airway function: a target for therapeutic intervention?. Pharmacol Ther 95 3 (2002) 239-257
18. Berger P., Tunon-De-Lara J.M., Savineau J.P., and Marthan R. Selected contribution: tryptase-induced PAR-2-mediated Ca(2+) signaling in human airway smooth muscle cells. J Appl Physiol 91 2 (2001) 995-1003
19. Somasundaram P., Ren G., Nagar H., Kraemer D., Mendoza L., Michael L.H., et al. Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts. J Pathol 205 1 (2005) 102-111
20. Cicala C., Pinto A., Bucci M., Sorrentino R., Walker B., et al. Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. Circulation 99 19 (1999) 2590-2597
21. Vergnolle N. Review article: proteinase-activated receptors-novel signals for gastrointestinal pathophysiology. Aliment Pharmacol Ther 14 3 (2000) 257-266
22. Crowe S.E., and Perdue M.H. Gastrointestinal food hypersensitivity: basic mechanisms of pathophysiology. Gastroenterology 103 3 (1992) 1075-1095
23. Crowe S.E., Luthra G.K., and Perdue M.H. Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease. Gut 41 6 (1997) 785-792
24. Nguyen T.D., Moody M.W., Steinhoff M., Okolo C., Koh D.S., and Bunnett N.W. Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest 103 2 (1999) 261-269
25. Berge A. PAR-2 antagonists-the next generation of anti-inflammatories?. Br Med J 320 (2000) 334
26. Steinhoff M., Vergnolle N., Young S.H., Tognetto M., Amadesi S., et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6 2 (2000) 151-158
27. Samoszuk M., Corwin M., and Hazen S.L. Effects of human mast cell tryptase on the kinetics of blood clotting. Thromb Res 109 2-3 (2003) 153-156
28. Schwartz L.B., Metcalfe D.D., Miller J.S., Earl H., and Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 316 26 (1987) 1622-1626
29. Enander I., Matsson P., Nystrand J., Andersson A.S., Eklund E., Bradford T.R., et al. A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies. J Immunol Methods 138 1 (19918) 39-46
30. Schwartz L.B., Bradford T.R., Rouse C., Irani A.M., Rasp G., Van der Zwan J.K., et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 14 3 (1994) 190-204
31. UniCAP Tryptase Fluoroenzymeimmunoassay Instruction Manual, Pharmacia and Upjohn 2001.
32. Enrique E., Garcia-Ortega P., Sotorra O., Gaig P., and Richart C. Usefulness of UniCAP-tryptase fluoroimmunoassay in the diagnosis of anaphylaxis. Allergy 54 6 (1999) 602-606
33. Brown S.G., Blackman K.E., and Heddle R.J. Can serum mast cell tryptase help diagnose anaphylaxis?. Emerg Med Australas 16 2 (2004) 120-124
34. Fisher MM. Investigation of a suspected anaphylactic or anaesthetic drug allergy reaction accessed www.usyd.edu.au/anaes/austan/anaphylaxis.html
35. Yunginger J.W., Nelson D.R., Squillace D.L., Jones R.T., Holley K.E., Hyma B.A., et al. Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci 36 3 (1991) 857-865
36. Randall B., Butts J., and Halsey J.F. Elevated postmortem tryptase in the absence of anaphylaxis. J Forensic Sci 40 2 (1995) 208-211
37. Horn K.D., Halsey J.F., and Zumwalt R.E. Utilization of serum tryptase and immunoglobulin assay in the postmortem diagnosis of anaphylaxis. Am J Forensic Med Pathol 25 1 (2004) 37-43
38. Mertes P.M., and Laxenaire M.C. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 19 4 (2002) 240-262
39. Fisher M.M., and Baldo B.A. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 12 2 (1993) 97-104
40. Currie M., Webb R.K., Williamson J.A., Russell W.J., and Mackay P. The Australian Incident Monitoring Study. Clinical anaphylaxis: an analysis of 2000 incident reports. Anaesth Intensive Care 21 5 (1993) 621-625
41. Albrech C., Widmer S., Beaudoin E., Moneret-Vautrin D.A., and Laxenaire M.C. Prevalence of muscle relaxant sensitivity in a general population: implications for a preoperative screening. Clin Exp Allergy 29 (1999) 72-75
42. Laxenaire M.C. Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994-December 1996). Ann Fr Anesth Reanim 18 7 (1999) 796-809 [in French]
43. Pepys J., Pepys E.O., Baldo B.A., and Whitwam J.G. Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents. Skin prick tests in aetiological diagnosis. Anaesthesia 49 6 (1994) 470-475
44. Moscicki RA, Sockin SM, Corsello BF, Ostro MG, Bloch KJ. Anaphylaxis during induction of general anesthesia: subsequent evaluation and management. J Allergy Clin Immunol 1990;86(3, Part 1):325-32.
45. Knowles S.R., Weber E., and Shear N.H. Allergic reactions during general anesthesia. J Allergy Clin Immunol 97 (1996) 344
46. Laxenaire M- C., and Moneret-Vautrin D.A. Allergy and anesthesia. Cur Opin Anesthesiol 5 (1992) 436-441
47. Fisher M.M., and Baldo B.A. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 80 1 (1998) 26-29
48. Laxenaire M.C. Drugs and other agents involved in anaphylactic shock occurring during anaesthesia. A French multicenter epidemiological inquiry. Ann Fr Anesth Reanim 12 2 (1993) 91-96
49. Laxenaire M.C. Substances responsible for peranesthetic anaphylactic shock. A third French multicenter study (1992-94). Ann Fr Anesth Reanim 15 8 (1996) 1211-1218 [in French]
50. Mertes P.M., Laxenaire M.C., and Alla F. Groupe d'Etudes des Reactions Anaphylactoides Peranesthesiques. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 99 3 (2003) 536-545
51. Lieberman P. Anaphylactic reactions during surgical and medical procedures. J Allergy Clin Immunol 110 2, Suppl (2002) S64-S69
52. Fisher M.M., and Doig G.S. Prevention of anaphylactic reactions to anaesthetic drugs. Drug Saf 27 6 (2004) 393-410
53. Mertes P.M., and Laxenaire M.C. Allergy and anaphylaxis in anaesthesia. Minerva Anestesiol 70 5 (2004) 285-291
54. Laroche D., Vergnaud M.C., Sillard B., Soufarapis H., and Bricard H. Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase. Anesthesiology 75 6 (1991) 945-949
55. Dybendal T., Guttormsen A.B., Elsayed S., Askeland B., Harboe T., and Florvaag E. Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia. Acta Anaesthesiol Scand 47 10 (2003) 1211-1218